Recursion Pharmaceuticals annual gross margin
2020
2021
2022
2023
2024
2025
Recursion Pharmaceuticals Gross Margin Growth & History (RXRX)
Recursion Pharmaceuticals's gross margin was 4.99% for fiscal 2025.
View full Recursion Pharmaceuticals company overviewRecursion Pharmaceuticals annual gross margin history
| Fiscal year | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | 4.99% | −18.12 pp |
| 2024 | 2024-12-31 | 23.12% | +18.66 pp |
| 2023 | 2023-12-31 | 4.46% | +25.62 pp |
| 2022 | 2022-12-31 | −21.16% | −121.16 pp |
| 2021 | 2021-12-31 | 100.00% | 0.00 pp |
| 2020 | 2020-12-31 | 100.00% | — |
Recursion Pharmaceuticals quarterly gross margin
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | −49.82% | −44.94 pp |
| Q1 2026 | 2026-03-31 | −92.99% | −44.94 pp |
| Q4 2025 | 2025-12-31 | 59.83% | +241.26 pp |
| Q3 2025 | 2025-09-30 | −183.81% | −237.50 pp |
| Q2 2025 | 2025-06-30 | −4.88% | −41.07 pp |
| Q1 2025 | 2025-03-31 | −48.04% | −67.10 pp |
| Q4 2024 | 2024-12-31 | −181.43% | −190.72 pp |
| Q3 2024 | 2024-09-30 | 53.69% | +56.95 pp |
| Q2 2024 | 2024-06-30 | 36.19% | +21.35 pp |
| Q1 2024 | 2024-03-31 | 19.05% | +21.64 pp |
| Q4 2023 | 2023-12-31 | 9.28% | −11.45 pp |
| Q3 2023 | 2023-09-30 | −3.27% | +13.82 pp |
| Q2 2023 | 2023-06-30 | 14.84% | +100.23 pp |
| Q1 2023 | 2023-03-31 | −2.59% | +43.65 pp |
| Q4 2022 | 2022-12-31 | 20.74% | −79.26 pp |
| Q3 2022 | 2022-09-30 | −17.09% | −117.09 pp |
| Q2 2022 | 2022-06-30 | −85.39% | −185.39 pp |
| Q1 2022 | 2022-03-31 | −46.24% | −146.24 pp |
| Q4 2021 | 2021-12-31 | 100.00% | — |
| Q3 2021 | 2021-09-30 | 100.00% | — |
| Q2 2021 | 2021-06-30 | 100.00% | — |
| Q1 2021 | 2021-03-31 | 100.00% | — |
Recursion Pharmaceuticals gross margin trends
Over the last five fiscal years, Recursion Pharmaceuticals's gross margin decreased from 100.00% to 4.99%, a change of −95.01 percentage points. The latest reported quarter, Q2 2026, shows −49.82%.
About the metric
What gross margin means
Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.
Calculation and source
How gross margin is calculated
TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Recursion Pharmaceuticals source filings ↗